comparemela.com

Latest Breaking News On - Clinical trials arena - Page 1 : comparemela.com

ASCO 24: Data shows survival benefit with J&J s subcutaneous Rybrevant

J&J's Rybrevant is expected to generate $4bn in sales by 2030, as per GlobalData estimates.

United statesAstrazeneca tagrissoEuropean medicines agencyAmerican society of clinical oncologyAmerican societyClinical oncologyAnnual meetingJohnson innovative medicineBiologics license applicationClinical trials arena

Apellis and Sobi report data from Phase II C3 glomerulopathy trial

Pegcetacoplan treatment resulted in sustained improvements in proteinuria and kidney function stabilisation.

Caroline baumalApellis pharmaceuticalsClinical trials arena

Novartis atrasentan shows to reduce proteinuria in Phase III IgAN trial

Atrasentan’s safety profile in the trial was deemed favourable, aligning with previous data.

David soergelMetabolism development unitDrug administrationClinical trials arena

Imvax concludes enrolment in Phase IIb glioblastoma treatment trial

The company secured $35m in financing to support IGV-001’s clinical development.

John fureyDrug administrationClinical trials arena

Eli Lilly s mirikizumab shows promise in Phase III Crohn s disease trial

Mirikizumab demonstrated significant improvements in Crohn's disease patients.

Eli lillyMark genoveseDrug administrationEuropean medicines agencyLilly immunologyClinical trials arena

vimarsana © 2020. All Rights Reserved.